Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 9, 2023
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
Raghuram Selvaraju Reiterated (AVXL) at Strong Buy and Held Target at $50 on, Feb 9th, 2023
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Anavex Life Sciences Corp." (AVXL) at Strong Buy and Held Target at $50 on, Feb 9th, 2023.
Raghuram has made no other calls on AVXL in the last 4 months.
There is 1 other peer that has a rating on AVXL. Out of the 1 peers that are also analyzing AVXL, all agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Charles Duncan of "Cantor Fitzgerald" Downgraded from Buy to Hold and Decreased Target to $11 on, Tuesday, December 6th, 2022
